State Street’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.6M Buy
3,509,110
+117,260
+3% +$1.09M ﹤0.01% 1918
2025
Q1
$24.9M Sell
3,391,850
-98,039
-3% -$719K ﹤0.01% 2003
2024
Q4
$29.8M Buy
3,489,889
+13,597
+0.4% +$116K ﹤0.01% 1989
2024
Q3
$30.2M Sell
3,476,292
-444,371
-11% -$3.87M ﹤0.01% 1974
2024
Q2
$26.8M Buy
3,920,663
+1,518,283
+63% +$10.4M ﹤0.01% 2013
2024
Q1
$21.9M Buy
2,402,380
+862,805
+56% +$7.85M ﹤0.01% 2155
2023
Q4
$6.87M Sell
1,539,575
-242,290
-14% -$1.08M ﹤0.01% 2783
2023
Q3
$5.6M Buy
1,781,865
+205,652
+13% +$646K ﹤0.01% 2868
2023
Q2
$8.13M Buy
1,576,213
+83,254
+6% +$430K ﹤0.01% 2753
2023
Q1
$7.87M Buy
1,492,959
+105,627
+8% +$557K ﹤0.01% 2792
2022
Q4
$3.9M Sell
1,387,332
-12,014
-0.9% -$33.8K ﹤0.01% 3139
2022
Q3
$5.81M Sell
1,399,346
-12,481
-0.9% -$51.8K ﹤0.01% 2992
2022
Q2
$5.68M Sell
1,411,827
-293,107
-17% -$1.18M ﹤0.01% 3043
2022
Q1
$8.44M Sell
1,704,934
-25,422
-1% -$126K ﹤0.01% 2904
2021
Q4
$12.1M Buy
1,730,356
+57,306
+3% +$399K ﹤0.01% 2802
2021
Q3
$16.7M Sell
1,673,050
-65,422
-4% -$654K ﹤0.01% 2591
2021
Q2
$24.7M Buy
1,738,472
+220,855
+15% +$3.13M ﹤0.01% 2383
2021
Q1
$24.9M Buy
1,517,617
+62,663
+4% +$1.03M ﹤0.01% 2232
2020
Q4
$30.1M Buy
1,454,954
+305,487
+27% +$6.32M ﹤0.01% 1978
2020
Q3
$8.75M Buy
1,149,467
+243,485
+27% +$1.85M ﹤0.01% 2502
2020
Q2
$7.55M Buy
905,982
+89,781
+11% +$748K ﹤0.01% 2567
2020
Q1
$4.04M Buy
816,201
+109,634
+16% +$543K ﹤0.01% 2735
2019
Q4
$2.79M Buy
706,567
+33,671
+5% +$133K ﹤0.01% 3126
2019
Q3
$2.05M Buy
672,896
+92,165
+16% +$280K ﹤0.01% 3211
2019
Q2
$2.56M Buy
580,731
+59,405
+11% +$261K ﹤0.01% 3145
2019
Q1
$2.07M Buy
521,326
+36,649
+8% +$146K ﹤0.01% 3134
2018
Q4
$1.93M Buy
484,677
+11,383
+2% +$45.3K ﹤0.01% 3133
2018
Q3
$3.26M Buy
473,294
+40,314
+9% +$277K ﹤0.01% 3059
2018
Q2
$2.92M Buy
432,980
+59,057
+16% +$399K ﹤0.01% 3103
2018
Q1
$2.44M Buy
373,923
+21,782
+6% +$142K ﹤0.01% 3086
2017
Q4
$1.57M Buy
352,141
+261
+0.1% +$1.16K ﹤0.01% 3255
2017
Q3
$2.18M Sell
351,880
-20,043
-5% -$124K ﹤0.01% 3176
2017
Q2
$3.45M Buy
371,923
+40,782
+12% +$378K ﹤0.01% 2917
2017
Q1
$3.08M Buy
331,141
+92,220
+39% +$857K ﹤0.01% 2929
2016
Q4
$2M Buy
238,921
+42,761
+22% +$358K ﹤0.01% 3102
2016
Q3
$1.35M Sell
196,160
-9,149
-4% -$63K ﹤0.01% 3116
2016
Q2
$1.01M Sell
205,309
-277
-0.1% -$1.37K ﹤0.01% 3271
2016
Q1
$1.99M Buy
205,586
+24,939
+14% +$241K ﹤0.01% 3007
2015
Q4
$1.69M Buy
180,647
+3,698
+2% +$34.7K ﹤0.01% 3052
2015
Q3
$2.49M Buy
176,949
+52,049
+42% +$731K ﹤0.01% 2905
2015
Q2
$2.63M Buy
124,900
+54,771
+78% +$1.15M ﹤0.01% 2959
2015
Q1
$2.94M Buy
70,129
+23,029
+49% +$966K ﹤0.01% 2857
2014
Q4
$1.11M Buy
47,100
+7,200
+18% +$169K ﹤0.01% 3238
2014
Q3
$596K Buy
+39,900
New +$596K ﹤0.01% 3355